Home

Regulatory approval was based on data from Intact Vascular’s Tack optimized balloon angioplasty II (TOBA II) pivotal trial, which demonstrated the safety and effectiveness of the Tack implant to resolve dissections following angioplasty. Data from the pivotal trial were presented in a late-breaking scientific session at the 2018 VIVA conference.

“I look forward to having the Tack implant available for my patients,” says William Gray, system chief, Division of Cardiovascular Disease at Main Line Health, president, Lankenau Heart Institute and principal investigator for the TOBA II trial. “Post-angioplasty dissections can significantly impact patient outcomes. Having a minimal metal solution that specifically addresses dissections and improves angioplasty results while preserving future treatment options is extremely exciting.”

The inflation of an angioplasty balloon and resulting mechanical stress inherently injures vessels and creates dissections. These dissections are prevalent, underdiagnosed and underestimated. If left untreated, dissections can compromise clinical outcomes, resulting in acute thrombosis and arterial occlusions, leading to lower long-term patency rates and repeat procedures.

The TOBA II pivotal trial, notably the first peripheral vascular study to enrol patients with 100% dissected vessels, met all primary endpoints with 92% of dissections completely resolved following treatment. In this challenging patient population, the Tack implant demonstrated 79.3% Kaplan-Meier vessel patency and 86.5% Kaplan-Meier freedom from clinically driven reintervention at 12 months, with only a 0.5% bailout stent rate and zero implant fractures.

“FDA approval of the Tack Endovascular System comes at a dynamic time in the PAD market place. The Tack system’s unique combination of minimal metal and highly targeted dissection repair is an ideal fit with today’s focus on minimising inflammation and improving long term outcomes,” stated Bruce Shook, president and CEO of Intact Vascular. He added, “Now with the Tack Endovascular System available in both Europe and the USA, we look forward to expanding our commercialisation efforts and continuing to improve the quality of life for PAD patients.”

Intact Vascular recently announced its European launch and first commercial cases in several centres across Germany. With FDA approval granted, the company plans a limited initial release in the USA that will progress toward broader market commercialisation.

Source vascularnews.com

Duc Tin Clinic

Chia sẽ qua facebook bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua google bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua twitter bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua MySpace bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua LinkedIn bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua stumbleupon bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua icio bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua digg bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Chia sẽ qua yahoo bài: Intact Vascular’s Tack Endovascular System receives FDA approval

Tin tức liên quan

Vesteck completes first-in-human use of several Suture-Tight devices

Age is just a number: Individual patient data meta-analysis probes safety of CEA in the elderly

Artificial intelligence can predict risk of complications after endovascular aneurysm repair

Bluegrass Vascular announces Journal of Vascular Surgery paper reporting use of Surfacer system

Vascular access creation: EndoAVF keeps future options open, but is not a replacement for surgical fistulas

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.